A Narrative Review on Evaluation of Hypercoagulability State in Severe Covid-۱۹ Patients with Background Risk Factors

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 258

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ZUMS-28-131_001

تاریخ نمایه سازی: 11 اردیبهشت 1400

چکیده مقاله:

Coronavirus disease (COVID-۱۹) can induce coagulopathy at the base of sepsis-induced coagulopathy (SIC), which is an important cause of death in these patients. Cytokine storm causes imbalance in coagulation and fibrinolytic system. A combination of hypercoagulability state, decrease or inhibition of fibrinolysis and endotheliopathy causes thromboembolic events. Underlying diseases such as diabetes and hypertension with a high rate of mortality in COVID-۱۹ and some conditions like aging and obesity are the main disorders with hemostatic disturbance and increase of coagulopathy. Therefore, it seems that the combination of COVID-۱۹ infection and these risk factors increase the risk of thromboembolic complications all together.

نویسندگان

Minoosh Moghimi

Dept. of of Hematology-Medical Oncology, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Kasra Khodadadi

Dept. of Internal Medicine, Vali-e-Asr Hospital, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran

Yousef Mortazavi

Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Huang C, Wang Y, Li X, Ren L, Zhao J, ...
  • Coronavirus Resource Center, https://coronavirus.jhu.edu/map.html ;2020[accessed 24 May 2020][4]. Kannan S, ...
  • Gibson PG, Qin L, Puah SJMJA. COVID-19 ARDS: clinical features ...
  • Gandhi A, Görlinger KJJoCCCT. Coagulopathy in COVID-19: Connecting the Dots ...
  • Kitchens CSJAEPB. Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). ...
  • Iba T, Di Nisio M, Levy JH, Kitamura N, Thachil ...
  • Iba T, Levy J, Wada H, Thachil J, Warkentin T, ...
  • Iba T, Levy JH, Yamakawa K, Thachil J, Warkentin TE, ...
  • Taylor Jr FB, Toh C-H, Hoots KW, Wada H, Levi ...
  • Connors JM, Levy JHJB. COVID-19 and its implications for thrombosis ...
  • Guo W, Li M, Dong Y, Zhou H, Zhang Z, ...
  • Ashton AW, Ware JAJCr. Thromboxane A2 receptor signaling inhibits vascular ...
  • Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, ...
  • Bikdeli B, Madhavan MV, Jimenez D, Chuich T, Dreyfus I, ...
  • Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, ...
  • Liu PP, Blet A, Smyth D, Li HJC. The science ...
  • Tu W-J, Cao J, Yu L, Hu X, Liu QJIcm. ...
  • Tang N, Li D, Wang X, Sun ZJJoT, Haemostasis. Abnormal ...
  • Zhang D, Guo R, Lei L, Liu H, Wang Y, ...
  • Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, ...
  • Ciceri F, Beretta L, Scandroglio AM, Colombo S, Landoni G, ...
  • Skurk T, Lee Y-M, Hauner HJH. Angiotensin II and its ...
  • Takaya H, Yoshiji H, Kawaratani H, Sakai K, Matsumoto M, ...
  • Kuba K, Imai Y, Rao S, Gao H, Guo F, ...
  • Nicholls J, Peiris MJNm. Good ACE, bad ACE do battle ...
  • Zhou B, She J, Wang Y, Ma X. Utility of ...
  • Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, ...
  • Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, ...
  • Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, ...
  • Cui S, Chen S, Li X, Liu S, Wang FJJoT, ...
  • Chen N, Zhou M, Dong X, Qu J, Gong F, ...
  • De Taeye B, Smith LH, Vaughan DEJCoip. Plasminogen activator inhibitor-1: ...
  • Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, ...
  • Tian S, Hu W, Niu L, Liu H, Xu H, ...
  • Yao X, Li T, He Z, Ping Y, Liu H, ...
  • Boccia M, Aronne L, Celia B, Mazzeo G, Ceparano M, ...
  • Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, ...
  • Wang D, Hu B, Hu C, Zhu F, Liu X, ...
  • Huang C, Wang Y, Li X, et al. Clinical features ...
  • Grant PJ. Diabetes mellitus as a prothrombotic condition. Journal of ...
  • Carr MEJJoD, Complications i. Diabetes mellitus: a hypercoagulable state. 2001;15(1):44-54. ...
  • Stein PD, Goldman J, Matta F, Yaekoub AYJTAjotms. Diabetes mellitus ...
  • Peng Y-H, Lin Y-S, Chen C-H, Tsai K-Y, Hung Y-C, ...
  • journal EAPSGJEh. ECAT angina pectoris study: baseline associations of haemostatic ...
  • Stone M, Thorp JJJCGP. Plasma fibrinogen—a major coronary risk factor. ...
  • Li Y, Zhao K, Wei H, Chen W, Wang W, ...
  • Lip GJJohh. Hypertension and the prothrombotic state. 2000;14(10):687-90. https://doi: 10.1038/sj.jhh.1001051 ...
  • Pedrinelli R, Dell'omo G, Catapano G, Giampietro O, Carmassi F, ...
  • Blann A, Naqvi T, Waite M, McCollum CJJohh. von Willebrand ...
  • Lip GY, DPhil AFJ, Beevers DGJTAjoc. Relation of endothelium, thrombogenesis, ...
  • Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, ...
  • Peng H, Yeh F, de Simone G, Best LG, Lee ...
  • Gavriilaki E, Gkaliagkousi E, Nikolaidou B, Triantafyllou G, Chatzopoulou F, ...
  • Gleerup G, Vind J, Winther KJEjoci. Platelet function and fibrinolytic ...
  • Kiechl S, Willeit JJA, thrombosis,, biology v. The natural course ...
  • Balleisen L, Bailey J, Epping P, Schulte H, Van de ...
  • Loskutoff DJ, Sawdey M, Mimuro JJPih, thrombosis. Type 1 plasminogen ...
  • Hashimoto Y, Kobayashi A, Yamazaki N, Sugawara Y, Takada Y, ...
  • Abbate R, Prisco D, Rostagno C, Boddi M, Gensini GF. ...
  • Razak A, Binti N, Jones G, Bhandari M, Berndt MC, ...
  • Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, ...
  • Desai A, Sachdeva S, Parekh T, Desai RJJgo. COVID-19 and ...
  • Merad M, Martin JC. Pathological inflammation in patients with COVID-19: ...
  • Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis ...
  • نمایش کامل مراجع